What is the price per box of bedaquiline after medical insurance reimbursement?

Bedaquiline (Bedaquiline) is a new anti-tuberculosis drug used to treat multi-drug-resistant tuberculosis (MDR-TB). Its domestic launch is regarded as an important progress in the field of tuberculosis management. With the inclusion of Bedaquiline Fumarate Tablets in the National Medical Insurance List, the financial burden faced by patients during treatment has been greatly alleviated. According to the current market conditions, the common specification of this drug is 100 mg × 24 tablets per box, with a retail price of approximately RMB 10,000. However, due to the implementation of the national medical insurance policy, this drug has been classified as a Class B medical insurance drug and can enjoy medical insurance subsidies in different regions and different reimbursement ratios, thus significantly reducing the patient's out-of-pocket amount.

The specific price after medical insurance reimbursement is affected by multiple factors such as local medical insurance policies, reimbursement ratios, and patient status (such as whether it is outpatient chronic disease or inpatient treatment). For example, in some first-tier cities or areas with strong medical insurance payment capabilities, the reimbursement ratio can be as high as 70%-90%. In this case, the patient's out-of-pocket cost per box of bedaquiline may be reduced to a thousand yuan. In some areas, if the drug is included in the outpatient chronic disease management catalog, patients can directly use the medical insurance settlement through the outpatient clinic, and do not need to be hospitalized to be reimbursed. In addition, some provinces and cities, in conjunction with special tuberculosis prevention and treatment policies, have implemented "zero out-of-pocket payment" or set up special drug subsidies for specific groups of people, which has further alleviated the financial pressure on MDR-TB patients.

It is worth noting that the adjustment of the medical insurance catalog is carried out dynamically, and different provinces and cities may have slightly different implementation plans in drug negotiation, drug price setting and reimbursement management. Therefore, patients who want to use bedaquiline can consult local policies at the hospital where they are treated or the local medical insurance bureau to understand the most accurate reimbursement ratio and co-pay amount.

Reference materials:https://en.wikipedia.org/wiki/Bedaquiline